David Cella, PhD

home / authors / david-cella-phd

Articles

Dr. Cella on Patient-Reported Outcomes in a Clinical Setting

Dr. Cella on Patient-Reported Outcomes in a Clinical Setting

David Cella, PhD
July 12th 2011

Dr. David Cella from Northwestern University Feinberg School of Medicine on Patient-Reported Outcomes in a Clinical Setting

Dr. Cella on the Value of Patient-Reported Outcomes

Dr. Cella on the Value of Patient-Reported Outcomes

David Cella, PhD
July 6th 2011

Dr. David Cella from Northwestern University Feinberg School of Medicine on the Value of Patient-Reported Outcomes

Dr. Cella on Patient Reported Data's Cost Effectiveness

Dr. Cella on Patient Reported Data's Cost Effectiveness

David Cella, PhD
June 29th 2011

Dr. David Cella from Northwestern University Feinberg School of Medicine on Quality of Life Assessments' Cost Effectiveness

Dr. Cella on the Increase in Quality of Life Assessments

Dr. Cella on the Increase in Quality of Life Assessments

David Cella, PhD
June 24th 2011

Dr. David Cella from Northwestern University Feinberg School of Medicine Explains the Increase in Quality of Life Assessments

Latest Updated Articles

ASCO Offers an ‘Eye-Opening Experience’ for Nurse Practitioners
Published: June 23rd 2024 | Updated: July 27th 2024
ASCO Offers an ‘Eye-Opening Experience’ for Nurse Practitioners
Close up of hand touching smartwatch with health app on the screen, gadget for fitness active lifestyle. © sitthiphong - stock.adobe.com
Published: April 11th 2024 | Updated: July 27th 2024
Navigating Wearable Technology in Oncology Nursing While Avoiding Data Fatigue
Unlocking Bladder Cancer: A Guide to Effective Diagnosis and Staging
Published: July 11th 2023 | Updated: July 27th 2024
Unlocking Bladder Cancer: A Guide to Effective Diagnosis and Staging
Case Study: Recognizing the Typical Signs of Bladder Cancer
Published: July 11th 2023 | Updated: July 27th 2024
Case Study: Recognizing the Typical Signs of Bladder Cancer
FDA OKs Blinatumomab for Children, Adults with CD-19 B-ALL in Consolidation Phase
Published: June 14th 2024 | Updated: July 27th 2024
FDA OKs Blinatumomab for Children, Adults with CD-19 B-ALL in Consolidation Phase
With APP Help, Cancer Clinical Trials No Longer a ‘Last-Ditch’ Option
Published: April 28th 2024 | Updated: July 27th 2024
With APP Help, Cancer Clinical Trials No Longer a ‘Last-Ditch’ Option
© 2024 MJH Life Sciences

All rights reserved.